Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

OptimizeRx Corporation - Common Stock (NQ:OPRX)

8.360 -0.090 (-1.07%)
Streaming Delayed Price Updated: 1:33 PM EDT, Apr 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 39,474
Open 8.560
Bid (Size) 8.310 (1)
Ask (Size) 8.380 (2)
Prev. Close 8.450
Today's Range 8.230 - 8.807
52wk Range 3.780 - 14.13
Shares Outstanding 17,618,607
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
OptimizeRx Corporation Announces Plan for Additional Board of Directors Refreshment
From OptimizeRx Corporation
Via GlobeNewswire
Unusual volume stocks in Thursday's session
Let's have a look at what is happening on the US markets on Thursday. Below you can find the stocks with an unusual volume in today's session. 
Via Chartmill

Performance

YTD
+60.5%
+60.5%
1 Month
-3.1%
-3.1%
3 Month
+54.5%
+54.5%
6 Month
+37.7%
+37.7%
1 Year
-8.0%
-8.0%

More News

Read More
Top movers in Wednesday's session
Via Chartmill
Where OptimizeRx Stands With Analysts
Via Benzinga
The Analyst Verdict: OptimizeRx In The Eyes Of 6 Experts
Via Benzinga
Earnings Scheduled For November 13, 2024
Via Benzinga
Preview: OptimizeRx's Earnings
Via Benzinga
Which stocks are experiencing notable movement on Wednesday?
Via Chartmill
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Let's uncover which stocks are experiencing notable gaps during today's session.
Via Chartmill
OptimizeRx Clocks Double-Digit Revenue Growth In Q4, Forecasts Sales Of At Least $100 Million
Via Benzinga
OptimizeRx Reports Strong Fourth Quarter and Full Year 2024 Financial Results
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Corporation Confirms Receipt of Notice of Director Nominations
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Corporation Appoints Stephen Silvestro as Chief Executive Officer
From OptimizeRx Corporation
Via GlobeNewswire
Earnings Scheduled For March 12, 2025
Via Benzinga
OptimizeRx Sets Fourth Quarter and Full Year 2024 Financial Results Conference Call for March 12, 2025, at 8:30 a.m. ET
From OptimizeRx Corporation
Via GlobeNewswire
CrowdStrike To Rally Around 15%? Here Are 10 Top Analyst Forecasts For Tuesday
Via Benzinga
OptimizeRx Announces Departure of CEO William Febbo and Appointment of Stephen Silvestro as Interim CEO
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx to Participate in Upcoming Investor Conferences
From OptimizeRx Corporation
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
OptimizeRx Reports Third Quarter 2024 Financial Results
From OptimizeRx Corporation
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
OptimizeRx Sets Third Quarter 2024 Conference Call for November 13, 2024 at 4:30 p.m. ET
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Continues to Expand its Strategic Relationship with a Top-Tier Pharma Client via a Multi-Brand, Multi-Solution Investment Commitment with Over $10M In-Year Total Value
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Launches Novel Brand Eligibility Technology, Enabling Dynamic Direct to Consumer Marketing for Healthcare Audiences
From OptimizeRx Corporation
Via GlobeNewswire

Frequently Asked Questions

Is OptimizeRx Corporation - Common Stock publicly traded?
Yes, OptimizeRx Corporation - Common Stock is publicly traded.
What exchange does OptimizeRx Corporation - Common Stock trade on?
OptimizeRx Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for OptimizeRx Corporation - Common Stock?
The ticker symbol for OptimizeRx Corporation - Common Stock is OPRX on the Nasdaq Stock Market
What is the current price of OptimizeRx Corporation - Common Stock?
The current price of OptimizeRx Corporation - Common Stock is 8.360
When was OptimizeRx Corporation - Common Stock last traded?
The last trade of OptimizeRx Corporation - Common Stock was at 04/21/25 01:33 PM ET
What is the market capitalization of OptimizeRx Corporation - Common Stock?
The market capitalization of OptimizeRx Corporation - Common Stock is 147.29M
How many shares of OptimizeRx Corporation - Common Stock are outstanding?
OptimizeRx Corporation - Common Stock has 147M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.